You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus

Citation Tools

Article menu

Download PDFPDF

Clinical trials and drug discovery
Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Merrill JT, Furie R, Werth VP, et al
Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus
Lupus Science & Medicine 2018;5:e000284. doi: 10.1136/lupus-2018-000284